NATURAL PEPTIDE COMPLEXES OF THYMUS AND KIDNEYS REINFORCE APOPTOSIS OF TRANSFORMED T-CELLS, BUT DO NOT AFFECT THE PROCESSES OF APOPTOSIS IN B-CELLS

  • O.A. Shlykova Ukrainian Medical Stomatological Academy, Poltava
  • O.V. Izmailova Ukrainian Medical Stomatological Academy, Poltava
  • Yu.V. Lysanets Ukrainian Medical Stomatological Academy, Poltava
Keywords: apoptosis, natural peptide complexes of thymus and kidneys, transformed T- and B-cells.

Abstract

One of the most important issues in modern medicine is the search for methods for regulating programmed cell death in order to develop new approaches to treatment, including cancer and leukemia. Humoral regulation of theprocesses of apoptosis with the help of cytokines, hormones, growth factors, peptides plays an important role in the mechanisms of regulation of apoptosis. The effect of natural peptide complexes of thymus and kidneys on HPB-ALL (acute T-cell leukemia) and BJAB (Berkita lymphoma) cell apoptosis processes has been studied. It has been shown that the natural peptide complexes of the thymus and the kidneys have little stimulating effect on the apoptosis of BJAB tumor B cells at low concentrations, and when increasing the dose of peptides, they do not affect the processes of apoptosis; it is believed that the processes of elimination of transformed T-cells are enhanced by activating apoptosis processes in them. With the action of the natural peptide complex of thymus, this effect has a dose-dependent nature - increases with raising the dose.

Downloads

Download data is not yet available.

References

1. VDAC2 enables BAX to mediate apoptosis and limit tumor development / H.S. Chin, M.X. Li, I.K.L. Tan [et al.] // Nat. Commun. – 2018. – Vol. 9 (1). – P. 4976.
2. Kaser H.E. The role of apoptosis in normal ontogenesis and solid human neoplasms / H.E. Kaser, B. Bodey // In. Viv. – 2000. – Vol. 14, N. 6. – P. 789-803.
3. Reed J.C. Apoptosis-based therapies for hematologic malignancies / J.C. Reed, M. Pellecchia // Blood. – 2005. – Vol. 106. – P. 408-418.
4. Cheredeev A.N. Apoptoz kak vazhnyy etap ozenki immunnoy sistemy po patogeneticheskomu prinzipu / A.N. Cheredeev, L.V. Koval'chuk // Klinicheskaya laboratornaya diagnostika. – 1997. – № 7. – S. 31-34.
5. Johnstone R.W. Apoptosis: A Link between Cancer Genetics and Chemotherapy / R.W. Johnstone, A. A. Ruefli, S.W. Lowe // Cell. – 2002. – Vol. 108. – P. 153-164.
6. PIM1 overexpression in T-cell lymphomas protects tumor cells from apoptosis and confers doxorubicin resistance by upregulating c-myc expression / X. Xiang, Di Yuan, Yao Liu [et al.] // Acta Biochim. Biophys. Sin. – 2018. – P. 1-7.
7. Methotrexate induces high level of apoptosis in canine lymphoma/leukemia cell lines / A. Pawlak, J. Kutkowska, B. Obminska-Mrukowicz [et al.] // Res. Vet. Sci. – 2017. – Vol. 114. – P. 518-523.
8. ONC201 selectively induces apoptosis in cutaneous T-cell lymphoma cells via activating pro-apoptotic integrated stress response and inactivating JAK/STAT and NF-kappaB pathways / X. Ni, X. Zhang, C.H. Hu [et al.] // Oncotarget. – 2017. – Vol. 8. – P. 61761-61776.
9. Tripeptid neogen usilivaet apoptoz T-limfozitov cheloveka pri ich otvete na mitogen / M.F. Nikonova, T.Yu. Grigor'eva, M.M. Litvina [i dr.] // Immunologiya. – 2000. – № 4. – S. 35-37.
10. Dracorhodin perchlorate induces apoptosis in primary fibroblasts from human skin hypertrophic scars via participation of caspase 3 / P. Zhang, J. Li, X. Tang [et al.] // Eur. J. Pharmacol. – 2014. – Vol. 728. – P. 82-92.
11. Anti-cancer activity of targeted pro-apoptotic peptides / H.M. Ellerby, W. Аrар, L.M. Ellerby [et al.] // Nat. Med. – 1999. – Vol. 5, N. 9. – P. 1032-1038.
12. Zinchenko S.V. Immunomodulyatory v kompleksnoy terapii onkologicheskich bol'nych (obzor literatury) / S.V. Zinchenko // Povolzhskiy onkologicheskiy vestnik. – 2014. – № 1. – S. 57-64.
13. Patent 10180 Ukraїna, MPK A61 K37/00. Sposіb oderzhannya bіologіchno aktivnoї rechovini, scho maє regeneratornu ta modulyuyuchu dіyu / Kaydashev І.P., Katrushov O.V.; zayavnik і patentovlasnik TOV «Farmapol». – № 94052069 ; zayavl. 30.05.1994 ; opubl. 15.05.2001, Byul. 4.
14. Metodi klіnіchnich ta eksperimental'nich doslіdzhen' v medizinі / [L.V. Berkalo, O.V. Bobovich, N.O. Bobrova ta іn.]; pіd red. І.P. Kaydasheva – Poltava: Polіmet, 2003. – 320 s.
15. Osobennosti indukzii apoptoza etopozidom v razlich-nych zlokachestvennych limfoidnych kletochnych liniyach cheloveka / Z.A. Butenko, M.P. Zavelevich, I.A. Smirno-va [i dr.] // Eksperimental'naya onkologiya. – 2000. – T. 22, № 1-2. – S. 26-31.
16. Traganos F. Lysosomal proton pump activity: Supravital cell staining with acridine orange differential leukocytes subpopulations / F. Traganos, Z. Darzynkiewicz // Meth. Cell Biol. – 1994. – N. 41. – P. 185-195.
17. Protein Tyrosine Kinases p53/56lyn і p72syk in MHC class I-Mediated signal Transduction in B-Lymphoma Cells / A.E. Pedersen, S. Bregenholt, S. Skov [et al.] // Experimental Cell Research. – 1998. – Vol. 240. – P. 144-150.
18. Kuznik B.I. Imunofan – sinteticheskiy peptidnyy preparat novogo pokoleniya: immunologicheskie i pato-geneticheskie aspekty klinicheskogo primeneniya / B.I. Kuznik, V.V. Lebedev // Immunologiya. – 1999. – № 1. – S. 25-30.
19. Kaydashev I.P. Rol' molekul MNS I klassa na opucho-levych T-kletkach v peredache peptidnogo signala / I.P. Kaydashev, O.A. Nozhinova // Іmunologіya ta alergologіya. – 2002. – № 2. – S. 22-25.
20. Samara P. Prothymosin Alpha and Immune Responses: Are We Close to Potential Clinical Applications? / P. Samara, K. Ioannou, O.E. Tsitsilonis // Vitam. Horm. – 2016. – Vol. 102. – P. 179-207.
Published
2018-10-30
How to Cite
Shlykova, O., Izmailova, O., & Lysanets, Y. (2018). NATURAL PEPTIDE COMPLEXES OF THYMUS AND KIDNEYS REINFORCE APOPTOSIS OF TRANSFORMED T-CELLS, BUT DO NOT AFFECT THE PROCESSES OF APOPTOSIS IN B-CELLS. The Medical and Ecological Problems, 22(3-4), 30-34. https://doi.org/10.31718/mep.2018.22.3-4.08